Accomplished regulatory life sciences lawyer, Paul Ranson, has joined Keystone Law’s budding life sciences team.

With 30 years’ experience and expert knowledge of the regulatory, commercial, intellectual property, and product liability, Paul specialises in serving the pharmaceutical, biotechnology, and medical device sectors on both an international and domestic scale.

He arrived at the firm from Pinsent Masons where he was partner and, as well as previously holding a partnership at another global firm, he also spent around a decade in-house – advising leading pharmaceutical companies including Smith Kline Beecham.

James Knight, Managing Director at Keystone Law commented,

“Paul’s skill set is a real boost to our active life sciences practice. His profound knowledge an understanding of the life sciences, pharmaceutical and technology industries will be a central asset to our increasing global client base.”